Revolutionary Diagnosis of Obstructive Sleep Apnea (OSA)
22-10-06
Revolutionary Diagnosis of Obstructive Sleep Apnea (OSA)
AmCAD-UO® uses artificial intelligence (AI) and ultrasound technologies to detect OSA is truly smart and innovative being selected for this year’s Taiwan Excellence Awards and CNBC News Project.
Taiwan Excellence Awards partner with CNBC news to drive awareness of 3 specially selected award-winning products from Taiwan and one of them is AmCAD-UO® using AI technology to detect OSA in about 10 minutes. The partnership includes featuring AmCAD-UO® in CNBC’s digital publications and unique advertising on the NASDAQ billboard in Times Square of New York from September 28 to October 04, 2022. AmCAD-UO® will also be featured in taxi advertising in several big cities, along with other media opportunities across the USA.
According to the project host, AmCAD-UO® is characterized by reinventing shapes for the use of ultrasound and gives the ultrasound whole new types of clinical use. AmCAD-UO® incorporates an ultrasound machine and the latest AI deep learning algorithms set new standards and lay the foundations for industry change in OSA diagnosis.
Take a look at the project ads on the CNBC website. Contact us to find out more about AmCAD-UO.
are the trademarks owned by AmCad in Taiwan and/or in other countries. Unauthorized use of the AmCAD trademarks is prohibited unless specifically authorized.